CAS 1190594-22-9

Formule : C21H23NO4

InChI : InChI=1S/C21H23NO4/c1-13(2)11-19(20(23)24)22-21(25)26-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h3-10,13,18-19H,11-12H2,1-2H3,(H,22,25)(H,23,24)/t19-/m0/s1/i1D3,2D3,11D2,13D,19D

Code InChI : CBPJQFCAFFNICX-QDXFTFMQSA-N

SMILES : [2H][C@@](C(=O)O)(C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Fmoc-[D₁₀]Leu-OH

CAS : 1190594-22-9

Han et al. used Fmoc-(D₁₀)-Leu-OH for obtaining labeled Ac-WL₅, a hexapeptide forming β-sheets in membranes. The aggregation of the tagged peptide was followed by neutron scattering.

Formule : C₂₁H₁₃D₁₀NO₄

Degré de pureté : 99.2%

Couleur et forme : White

Masse moléculaire : 363.5

Ref: 01-4071075

Fmoc-L-Leu-OH-d10

CAS : 1190594-22-9

Fmoc-L-Leu-OH-d10

Formule : C₂₁H₁₃D₁₀NO₄

Degré de pureté : ≥98 atom% D,≥96%(CP)

Masse moléculaire : 363.47

Ref: 54-DE3080

L-Leucine-d10-N-FMOC

CAS : 1190594-22-9, 35661-60-0

Formule : (CD₃)₂CDCD₂CD(NHFMOC)COOH

Degré de pureté : 98 atom % D

Couleur et forme : White Solid

Masse moléculaire : 363.48

Ref: 3U-D5492

L-Leucine-d10-N-FMOC

CAS : 1190594-22-9

Formule : C₂₁H₂₃NO₄

Masse moléculaire : 363.5

Ref: BE-MD-4425D10

Fmoc-Leu-OH-D10

CAS : 1190594-22-9

Fmoc-Leu-OH-D10 is a deuterated compound of Fmoc-Leu-OH. Fmoc-Leu-OH (T8638) has a CAS number of 35661-60-0. NPC 15199 is an anti-inflammatory agent.

Formule : C₂₁D₁₀H₁₃NO₄

Masse moléculaire : 363.47

Ref: TM-TMIR-0003

Fmoc-[D10]Leu-OH

Produit contrôlé

CAS : 1190594-22-9

Please enquire for more information about Fmoc-[D10]Leu-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formule : C₂₁H₁₃D₁₀NO₄

Degré de pureté : Min. 95%

Masse moléculaire : 363.47 g/mol

Ref: 3D-FF111392

Fmoc-L-Leu-OH-d10

Produit contrôlé

CAS : 1190594-22-9

Applications Fmoc-L-Leu-OH-d10 is the labeled analogue of Fmoc-L-Leu-OH (F625015), an amino acid derivative, used in peptide chemistry. It is also one of the novel PPARγ ligands that can activate PPARγ in different ways, that reduces osteoclasts differentiation, and thus are better therapeutic targets in diabetes than traditional antidiabetic drugs.
References Haochen, W., et al.: J. Cell. Biochem., 114, 1969 (2013)

Formule : C₂₁D₁₀H₁₃NO₄

Couleur et forme : Neat

Masse moléculaire : 363.4732

Ref: TR-F625017